Neoplasm, Metastatic
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial (NCT07722754) | Guangdong Provincial People's Hospital | 2026-08-01 |
| Study of Breath-holding as a Means to Reduce Tumor Motion From Breathing (NCT00178477) | University of Rochester | 2002-01-01 |
Track Neoplasm, Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.